Yu-Gang Dong Selected Research

4-aminoimidazole

10/2009	Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
4/2007	Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Gang Dong Research Topics

Disease

6	Cardiomegaly (Heart Hypertrophy) 01/2011 - 04/2007
5	Hypertrophy 01/2011 - 09/2009
3	Hypertension (High Blood Pressure) 11/2019 - 05/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 09/2010
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2015 - 10/2014
2	Infections 04/2009 - 04/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Paroxysmal ventricular fibrillation 11/2019
1	Atrial Fibrillation 12/2015
1	Stroke (Strokes) 12/2015
1	Ischemic Stroke 12/2015
1	Hemorrhage 12/2015
1	Ventricular Tachycardia 11/2015
1	Heart Failure 10/2014
1	Fibrosis (Cirrhosis) 12/2010
1	Inflammation (Inflammations) 12/2010
1	Myocardial Infarction 03/2010
1	Ventricular Fibrillation 02/2010
1	Infarction (Infarctions) 02/2010
1	Type 2 Diabetes Mellitus (MODY) 02/2010
1	Reperfusion Injury 02/2010
1	Ulcer 04/2009
1	Peptic Ulcer (Peptic Ulcers) 04/2009

Drug/Important Bio-Agent (IBA)

3	AMP-Activated Protein KinasesIBA 01/2011 - 04/2007
2	Antihypertensive Agents (Antihypertensives)IBA 11/2019 - 09/2009
2	AntioxidantsIBA 05/2012 - 09/2009
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 09/2010 - 03/2010
2	Adenosine Monophosphate (AMP)IBA 10/2009 - 04/2007
2	Protein Kinases (Protein Kinase)IBA 10/2009 - 04/2007
2	AICA ribonucleotide (ZMP)IBA 10/2009 - 04/2007
2	4-aminoimidazoleIBA 10/2009 - 04/2007
1	HDL LipoproteinsIBA 01/2020
1	AminopeptidasesIBA 11/2019
1	LipidsIBA 11/2019
1	LDL CholesterolIBA 11/2019
1	Warfarin (Coumadin)FDA LinkGeneric 12/2015
1	MacrolidesIBA 11/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2015
1	Nifedipine (Adalat)FDA LinkGeneric 12/2012
1	Valsartan (Vals)FDA Link 12/2012
1	Desoxycorticosterone Acetate (DOCA)FDA Link 05/2012
1	Acetates (Acetic Acid Esters)FDA Link 05/2012
1	Desoxycorticosterone (Deoxycorticosterone)IBA 05/2012
1	Endothelin-1 (Endothelin 1)IBA 05/2012
1	erucylphosphocholineIBA 05/2012
1	Endothelins (Endothelin)IBA 05/2012
1	SaltsIBA 05/2012
1	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2012
1	Endothelin A ReceptorIBA 05/2012
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2011
1	Metformin (Glucophage)FDA LinkGeneric 01/2011
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2010
1	allicinIBA 12/2010
1	Pharmaceutical PreparationsIBA 09/2010
1	AVE 0991IBA 09/2010
1	Angiotensin IIIBA 09/2010
1	AngiotensinsIBA 03/2010
1	KT 5823IBA 03/2010
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2010
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 03/2010
1	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2010
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2010
1	Rosiglitazone (Avandia)FDA Link 02/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2009
1	Small Interfering RNA (siRNA)IBA 10/2009
1	PPAR alphaIBA 10/2009
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2009
1	Atrial Natriuretic Factor (ANF)IBA 10/2009
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 09/2009
1	Mitogen-Activated Protein KinasesIBA 09/2009
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2009
1	geranylgeranylacetone (teprenone)IBA 04/2009
1	NF-kappa B (NF-kB)IBA 04/2007

Therapy/Procedure

3	Therapeutics 10/2014 - 04/2007
1	Aftercare (After-Treatment) 03/2010
1	Ligation 03/2010